There is a generalized systemic immune activation following HIV infection which subsides but still persists at low-grade or subclinical following initiation of ART involving activation of both CD4+ and CD8+ T cells expressing high levels of CD38 [74]. This evidence concerns the gene CD38 and HIV infectious disease.